Clinical Trials · NCT01149421
A Study of the Effect of LY2189265 on Blood Pressure and Heart Rate in Type 2 Diabetes
- Phase
- Phase 2
- Recruitment status
- Completed
- Sponsor
- Eli Lilly and Company
- Enrollment
- 755
- Start date
- Jun 2010
- Locations
- 76 sites, 8 countries
- Primary endpoint
- Change From Baseline to 16 Weeks in Mean 24-hour Systolic Blood Pressure (SBP)